Heart Transplant Recipients May Benefit From New Noninvasive Test To Assess Organ Rejection Risk
Executive Summary
Natera’s Prospera Heart Assessment is a simple blood test that can evaluate the risk of the body rejecting the donor organ after transplant surgery. It could potentially replace invasive biopsy, the current standard of care.